Methimazole to Treat Polymyositis and Dermatomyositis
Learn more about:
Related Clinical Trial
Study of M5049 in DM and PM Participants (NEPTUNIA)
Plexin D1 as a Potential Biomarker inPM/DM
Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
Evaluate the Safety, Tolerability and Efficacy of PN-101 in Patients With Refractory Polymyositis or Dermatomyositis
Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
High-intensity Strength Training in Myositis
Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
Environmental Risk Factors for the Anti-synthetase Syndrome
Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
Epidemiological Study of Inflammatory Myopathies in a French Region
Anakinra in Myositis
Adult and Juvenile Myositis
Predictor of Clinical Response to Acthar in Myositis
Environmental Risk Factors for Myositis in Military Personnel
myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies
Dermatomyositis and Polymyositis Registry
Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM
Study and Treatment of Inflammatory Muscle Diseases
Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Hand Function in Patients With Poly- or Dermatomyositis
Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
Methimazole to Treat Polymyositis and Dermatomyositis
Abatacept Treatment in Polymyositis and Dermatomyositis
Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis
A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy
Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)